Coyne Terrance P. — SEC Form 4 filings

SEC reporting owner CIK 1814876. 22 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2024-08-12 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Royalty Pharma plc (RPRX)EVP & CFO2235 legs · 910,401 sh · $38,955,90710

Form 4 filings — Coyne Terrance P.

FiledFormIssuerReported transactionsSource
2026-08-174Royalty Pharma plc (RPRX)Sale (S): 9,230 @ $58.59 · Sale (S): 1,772 @ $59.14EDGAR
2026-08-074Royalty Pharma plc (RPRX)Grant/award (A): 11,002 @ $0 · Gift (G): 18,500 (derivative) @ $0EDGAR
2026-05-284Royalty Pharma plc (RPRX)Sale (S): 64,399 @ $53.98EDGAR
2026-05-084Royalty Pharma plc (RPRX)Grant/award (A): 24,263 @ $0EDGAR
2026-04-304Royalty Pharma plc (RPRX)Sale (S): 32,916 @ $49.78 · Sale (S): 1,875 @ $49.78EDGAR
2026-04-024Royalty Pharma plc (RPRX)Sale (S): 1,875 @ $48.33 · Sale (S): 32,916 @ $48.33EDGAR
2026-03-254Royalty Pharma plc (RPRX)Sale (S): 32,916 @ $45.53 · Sale (S): 1,875 @ $45.53EDGAR
2026-03-044Royalty Pharma plc (RPRX)Sale (S): 22,487 @ $46.67 · Sale (S): 10,429 @ $47.01 · Sale (S): 1,292 @ $46.67 · Sale (S): 583 @ $47.01EDGAR
2026-02-254Royalty Pharma plc (RPRX)Sale (S): 32,916 @ $45.32 · Sale (S): 1,875 @ $45.32EDGAR
2026-02-134Royalty Pharma plc (RPRX)Grant/award (A): 26,626 @ $0EDGAR
2026-02-044Royalty Pharma plc (RPRX)Sale (S): 102,581 @ $42.08 · Sale (S): 108,759 @ $42.84 · Sale (S): 19,076 @ $43.29 · Sale (S): 5,843 @ $42.08 · Sale (S): 6,195 @ $42.84 · Sale (S): 1,087 @ $43.29EDGAR
2026-01-234Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $39.35 · Sale (S): 3,750 @ $39.35EDGAR
2026-01-064Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $38.42 · Sale (S): 3,750 @ $38.42EDGAR
2025-12-174Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $38.36 · Sale (S): 3,750 @ $38.36EDGAR
2025-12-034Royalty Pharma plc (RPRX)Sale (S): 65,832 @ $39.87 · Sale (S): 3,750 @ $39.87EDGAR
2025-11-264Royalty Pharma plc (RPRX)Sale (S): 55,146 @ $38.67 · Sale (S): 10,686 @ $37.96 · Sale (S): 3,126 @ $38.67 · Sale (S): 624 @ $37.96EDGAR
2025-11-194Royalty Pharma plc (RPRX)Sale (S): 65,844 @ $39.30 · Sale (S): 3,750 @ $39.30EDGAR
2025-11-074Royalty Pharma plc (RPRX)Grant/award (A): 6,168 @ $0EDGAR
2025-08-084Royalty Pharma plc (RPRX)Grant/award (A): 3,696 @ $0 · Gift (G): 1,000 (derivative) @ $0EDGAR
2025-05-204Royalty Pharma plc (RPRX)Grant/award (A): 1,807,277 (derivative) @ $0EDGAR
2025-05-094Royalty Pharma plc (RPRX)Grant/award (A): 48,646 @ $0EDGAR
2024-08-124Royalty Pharma plc (RPRX)Gift (G): 2,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1814876 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →